ORNBV Orion Oyj Class B

Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture

Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture

ORION CORPORATION

STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS

22 August 2023 at 14.00 EEST             

        

Change in Orion Group Executive Management Board as of February 1st, 2024Julia Macharey appointed Senior Vice President, People & Culture

Ms. Julia Macharey has been appointed Senior Vice President of Orion Group’s new People & Culture group-level function and member of the Executive Management Board of Orion Group as of February 1st 2024. She will report to President & CEO Liisa Hurme. She currently holds the position of Senior Vice President, Human Resources and Operational Development at Valmet and is a member of the Valmet Executive Team. Julia Macharey holds a Master of Science degree in Economics and a Bachelor of Arts degree.

“With this appointment, I wanted to support the implementation of our global growth strategy and to strengthen the building of Orion's corporate culture. Based on her previous experience and track record, Julia Macharey will bring both global organizational and business perspective to Orion," says Orion’s President & CEO Liisa Hurme.

“I am very excited about the opportunity of joining a team of world-class experts who endeavor to improve well-being through life-saving and life-improving medicines and treatments. Orion’s people-oriented culture based on working together to create high-quality products is only one of the many reasons why I am looking forward to supporting Orion on its growth path,” says Julia Macharey about the appointment.

The new People & Culture function will focus on developing Orion’s professionals, capabilities and company culture and supporting growth, and Human Resources will be at the heart of this new group-level function as of February 1st.

“Orion’s organisation has seen significant geographical expansion in recent years, and we want to continue developing our people and culture in a global and systematic way. I am excited about the new opportunities in this and I warmly welcome Julia to Orion and to our management team,” says Liisa Hurme.

ANNEX: CV of Julia Macharey



Julia Macharey

Born 1977

Finnish citizen



Education:

Master of Science in Economics, University of Jyväskylä, 2000

Bachelor of Arts (Intercultural Communication), University of Jyväskylä, 1999



Career:

Valmet

2019–              Senior Vice President, Human Resources and Operational Development

2014–2019        Senior Vice President, Human Resources



Metso Corporation, Metso Paper

2012–2013        Senior Vice President, Human Resources of Metso Pulp, Paper and Power segment



Pöyry Plc        

2007–2012        Vice President, Human Resources of Industry Business Group





Nokia Corporation

2006–2007        Senior Manager, Business HR of Manufacturing Solutions

2004–2006        Senior Manager, Business HR of Sourcing and Procurement

SCA Hygiene Products Ltd and GmbH

2000–2004        Human Resources Manager and various HR management responsibilities

Attachment:

  •  (image)

Orion Corporation

Liisa Hurme



President and CEO
    Olli Huotari



SVP, Corporate Functions
 

                                                

Contact person:

Liisa Hurme, President and CEO

tel. +358 50 966 2874,

Contact person for the media:

Terhi Ormio, VP, Communications

tel. + 358 50 966 4646,

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo, Finland



Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

 

Attachment



EN
22/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orion Oyj Class B

 PRESS RELEASE

Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026

Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES10 MARCH 2026 at 13.50 EET          Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 In accordance with a decision by the Board of Directors, Orion Corporation has on 10 March 2026 transferred altogether 172,778 Orion Corporation B shares held by the company as a share reward for earning period 2023–2025 and a reward for commitment part to the persons belonging to the Share-based Incentive Plan of Orion Group. The transfer i...

 PRESS RELEASE

Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026

Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026 ORION OYJ        PÖRSSITIEDOTE – MUUTOKSET OMIEN OSAKKEIDEN OMISTUKSESSA         10.3.2026 KLO 13.50          Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026 Orion Oyj:n hallituksen päätöksen mukaisesti Orion Oyj on 10.3.2026 luovuttanut yhteensä 172 778 kappaletta yhtiön hallussa olevaa Orion Oyj:n B-osaketta Orion-konsernin avainhenkilöiden kannustinjärjestelmään kuuluville henkilöille ansaintajaksolta 2023–2025 ja sitouttavan osakepalkkion osuutena maksettavana palkkiona. Luovutus perustuu yhtiökokouksen 23.3.2022 antamaan...

 PRESS RELEASE

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS6 March 2026 at 16.00 EET          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly and indirectly by BlackRock, Inc. and its funds increased on 5 March 2026 above five (5) per cent of Orion C...

 PRESS RELEASE

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        6.3.2026 KLO 16.00          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan ja välillisesti omistamien Orionin osakkeiden osuus on 5.3.2026 ylittänyt viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRock, Inc.:n ja sen rahastojen osu...

 PRESS RELEASE

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        5.3.2026 KLO 15.00          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan ja välillisesti omistamien Orionin osakkeiden osuus on 4.3.2026 alittanut viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRock, Inc.:n ja sen rahastojen osu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch